NCT06245343

Brief Summary

Patients' pulmonary functions and diffusion capacity worsen following lung cancer surgery. Diaphragmatic activity and lung compliance decrease due to surgery. Peripheral and respiratory muscle functions are impaired in patients with lung cancer, exercise capacity and physical activity level decreased. Patients have postural instability and balance problems. Inspiratory muscle training has increased inspiratory muscle strength in patients with lung cancer. However, there is no study investigating functional inspiratory muscle training in patients with lung cancer.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable lung-cancer

Timeline
7mo left

Started May 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress77%
May 2024Dec 2026

First Submitted

Initial submission to the registry

January 21, 2024

Completed
17 days until next milestone

First Posted

Study publicly available on registry

February 7, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

May 15, 2024

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2026

Last Updated

February 3, 2026

Status Verified

January 1, 2026

Enrollment Period

2.3 years

First QC Date

January 21, 2024

Last Update Submit

January 31, 2026

Conditions

Keywords

Lung cancerOxygen consumptionMuscle oxygenationBalancePhysical activityFunctional inspiratory muscle training

Outcome Measures

Primary Outcomes (5)

  • Oxygen Consumption

    Maximum exercise capacity will be assessed by symptom-limited cardiopulmonary exercise testing on a treadmill at gradually increasing speed and degree, and oxygen consumption will be measured during the test.

    Trough study completion, an average of 2 year

  • Muscle oxygenation

    Muscle oxygenation of the quadriceps femoris (during the exercise test) and the diaphragm, scalene muscles, sternocleidomastoid muscle, and rectus abdominis muscle (at rest) will be assessed with a muscle oxygen monitor.

    Trough study completion, an average of 2 year

  • Balance

    Balance will be evaluated using a balance assessment device.

    Trough study completion, an average of 2 year

  • Balance (timed up and go test)

    Balance will be evaluated a timed up and go test.

    Trough study completion, an average of 2 year

  • Physical activity level

    A multi-sensor activity monitor will be used to assess the level of physical activity.

    Trough study completion, an average of 2 year

Secondary Outcomes (13)

  • Respiratory Muscle Strength

    Trough study completion, an average of 2 year

  • Respiratory Muscle Endurance

    Trough study completion, an average of 2 year

  • Pulmonary function (Forced expiratory volume in the first second (FEV1))

    Trough study completion, an average of 2 year

  • Pulmonary function (Forced vital capacity (FVC))

    Trough study completion, an average of 2 year

  • Pulmonary function (FEV1/FVC)

    Trough study completion, an average of 2 year

  • +8 more secondary outcomes

Study Arms (2)

Functional inspiratory muscle training group

EXPERIMENTAL

Patients in the training group will be performed functional inspiratory muscle training with the PowerBreathe® (inspiratory muscle training device) device at 50% of the maximal inspiratory pressure.

Device: Functional inspiratory muscle training group

Control group

SHAM COMPARATOR

The control group will not be given any training during the study period.

Device: Control group

Interventions

Patients will be given fundamental inspiratory muscle training with the inspiratory muscle training device at 50% of the maximal inspiratory pressure 30 min/day, 3 days/week for 4 weeks online with a physiotherapist. On the other days of the week, the training will be used as a home program. In the 5th week, the functional inspiratory muscle training program will be started. Before the program begins, patients will be shown the exercises in the functional inspiratory muscle training program. Patients will be given functional inspiratory muscle training with the inspiratory muscle training device at 50% of the maximal inspiratory pressure 30 min/day, 3 days/week for 4 weeks online with a physiotherapist. On the other days of the week, fundamental inspiratory muscle training will be used as a home program. Pressure increases will be made weekly to 10 centimeters of water (cmH2O). Unsupervised training sessions will be followed by charts filled out by patients.

Functional inspiratory muscle training group

The control group will not be given any training during the 8-week period. After the study, the treatment applied to the training group will also be applied to the control group in order to ensure that the patients in the control group are not ethically deprived of rehabilitation.

Control group

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18-80 years with lung cancer
  • Patients who have undergone surgical treatment (wedge resection, segmentectomy, lobectomy, bilobectomy) for lung cancer
  • Lung cancer treatment completed, in remission and under follow-up

You may not qualify if:

  • According to the American Association of Sports Medicine (ACSM) with absolute and relative contraindications to exercise tests
  • Patients who are having comorbidities such as uncontrolled hypertension, diabetes mellitus, heart failure or atrial fibrillation
  • Patients who are having acute infection during evaluation
  • Patients who are having orthopedic, neurological, psychological, etc. problems that limit evaluations

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gazi University Faculty of Health Sciences Department of Physiotherapy and Rehabilitation, Cardiopulmonary Rehabilitation Unit

Ankara, Çankaya, 06490, Turkey (Türkiye)

RECRUITING

Related Publications (6)

  • Cooley ME. Symptoms in adults with lung cancer. A systematic research review. J Pain Symptom Manage. 2000 Feb;19(2):137-53. doi: 10.1016/s0885-3924(99)00150-5.

    PMID: 10699541BACKGROUND
  • Miserocchi G, Beretta E, Rivolta I. Respiratory mechanics and fluid dynamics after lung resection surgery. Thorac Surg Clin. 2010 Aug;20(3):345-57. doi: 10.1016/j.thorsurg.2010.03.001.

    PMID: 20619225BACKGROUND
  • Nomori H, Horio H, Fuyuno G, Kobayashi R, Yashima H. Respiratory muscle strength after lung resection with special reference to age and procedures of thoracotomy. Eur J Cardiothorac Surg. 1996;10(5):352-8. doi: 10.1016/s1010-7940(96)80094-7.

    PMID: 8737692BACKGROUND
  • Granger CL, McDonald CF, Irving L, Clark RA, Gough K, Murnane A, Mileshkin L, Krishnasamy M, Denehy L. Low physical activity levels and functional decline in individuals with lung cancer. Lung Cancer. 2014 Feb;83(2):292-9. doi: 10.1016/j.lungcan.2013.11.014. Epub 2013 Nov 26.

    PMID: 24360323BACKGROUND
  • Kocjan J, Gzik-Zroska B, Nowakowska-Lipiec K, Burkacki M, Suchon S, Michnik R, Czyzewski D, Adamek M. Thoracic surgery may alter body static balance via diaphragm dysfunction. PLoS One. 2022 Aug 31;17(8):e0273641. doi: 10.1371/journal.pone.0273641. eCollection 2022.

    PMID: 36044444BACKGROUND
  • de Oliveira Vacchi C, Martha BA, Macagnan FE. Effect of inspiratory muscle training associated or not to physical rehabilitation in preoperative anatomic pulmonary resection: a systematic review and meta-analysis. Support Care Cancer. 2022 Feb;30(2):1079-1092. doi: 10.1007/s00520-021-06467-4. Epub 2021 Aug 21.

    PMID: 34417883BACKGROUND

MeSH Terms

Conditions

Lung NeoplasmsMotor Activity

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesBehavior

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Gülsüm SERTTAŞ GÜVEN, MSc.

    Gazi University

    STUDY CHAIR
  • Ece BAYTOK, MSc.

    Gazi University

    PRINCIPAL INVESTIGATOR
  • Muhammet SAYAN, A. Prof. Dr

    Gazi University

    PRINCIPAL INVESTIGATOR
  • Ali ÇELİK, Prof. Dr.

    Gazi University

    PRINCIPAL INVESTIGATOR
  • Meral BOŞNAK GÜÇLÜ, Prof. Dr.

    Gazi University

    STUDY DIRECTOR

Central Study Contacts

Meral BOŞNAK GÜÇLÜ, Prof. Dr.

CONTACT

Gülsüm SERTTAŞ GÜVEN, MSc.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Triple-blind study; the patients will not be informed about training group or control group and they will be evaluated and trained at different places and times.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Parallel Assignment
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Study director, PT, PhD, Prof. Dr. Faculty of Health Sciences, Department of Cardiopulmonary Physiotherapy and Rehabilitation

Study Record Dates

First Submitted

January 21, 2024

First Posted

February 7, 2024

Study Start

May 15, 2024

Primary Completion (Estimated)

September 15, 2026

Study Completion (Estimated)

December 15, 2026

Last Updated

February 3, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations